GL1X · GenesisL1 explorer

MolNFT v1 · #102014 · protein

Zinc-free RPN11 in complex with RPN8

4O8Y · 26S proteasome regulatory subunit RPN8: “Zinc-free RPN11 in complex with RPN8”. X-ray diffraction, 4 pockets (best druggability 0.80). MolNFT v1 #102014 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4O8Y
Type
protein
Length
340 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
26S proteasome regulatory subunit RPN8; 26S proteasome regulatory subunit RPN11
UniProt
Q08723, P43588
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A26S proteasome regulatory subunit RPN8protein17430% helix, 36% strandQ08723
B26S proteasome regulatory subunit RPN11protein16630% helix, 32% strandP43588

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 21 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13410.800.9052EDO
21030.390.7619EDO
3950.360.7414EDO
4900.350.7518EDO

Interfaces

1 interface between chains.

  • A–B · 2128 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 4O8Y · Zinc-free Rpn11 in complex with Rpn8 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08723 · AlphaFold monomer V2.0 prediction for 26S proteasome regulatory subunit RPN8 (Q08723) · a predicted model of the same protein · chain A against A, TM-score 0.95
  • P43588 · AlphaFold monomer V2.0 prediction for ubiquitin carboxyl-terminal hydrolase RPN11 (P43588) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.